Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 11Observational 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Breast Neoplasms 114Neoplasms 111Lung Neoplasms 68Prostatic Neoplasms 58Colorectal Neoplasms 49Carcinoma, Non-Small-Cell Lung 44Pancreatic Neoplasms 31Hematologic Neoplasms 29Multiple Myeloma 24Leukemia, Myeloid, Acute 24Carcinoma, Hepatocellular 23Stomach Neoplasms 21Ovarian Neoplasms 21Brain Neoplasms 21Melanoma 20Lymphoma 20Esophageal Neoplasms 20Urinary Bladder Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Disease 18Head and Neck Neoplasms 17Liver Neoplasms 16Colonic Neoplasms 16Uterine Cervical Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Carcinoma, Renal Cell 15Leukemia 14Endometrial Neoplasms 14Lymphoma, Non-Hodgkin 13Kidney Neoplasms 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Immunoglobulin Light-chain Amyloidosis × 30 days × Clear all
NCT07585331 2026-05-13

Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance

Fondazione IRCCS Policlinico San Matteo di Pavia

Completed
250 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT07448935 2026-05-06

ALPS

Fondazione IRCCS Policlinico San Matteo di Pavia

Recruiting
100 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, POEMS Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡